These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 31423747)

  • 21. [Correlation of serum Bio-intact PTH (1-84) and parathyroid gland size in hemodialysed patients].
    Inaba M; Imanishi Y; Ueda M; Cho H; Tahara H; Ishimura E; Nishizawa Y; Yamakawa T; Okuno S
    Clin Calcium; 2005 Sep; 15 Suppl 1():64-6; discussion 66-7. PubMed ID: 16272632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of Lowering Dialysate Calcium Concentration on Mineral and Bone Disorders in Chronic Hemodialysis Patients: Conversion from 3.0 mEq/L to 2.75 mEq/L.
    Yamada S; Ueki K; Tokumoto M; Suehiro T; Kimura H; Taniguchi M; Fujimi S; Kitazono T; Tsuruya K
    Ther Apher Dial; 2016 Feb; 20(1):31-9. PubMed ID: 26482334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Calcium-mediated parathyroid hormone suppression test in uraemic secondary hyperparathyroidism.
    Xiang T; Wang Y; Lan T; Zhou L
    Nephrology (Carlton); 2021 Feb; 26(2):164-169. PubMed ID: 33058364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel parathyroid hormone (1-84) assay as basis for parathyroid hormone monitoring in renal hyperparathyroidism.
    Kaczirek K; Prager G; Riss P; Wunderer G; Asari R; Scheuba C; Bieglmayer C; Niederle B
    Arch Surg; 2006 Feb; 141(2):129-34; discussion 134. PubMed ID: 16490888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect Modifying Role of Serum Calcium on Mortality-Predictability of PTH and Alkaline Phosphatase in Hemodialysis Patients: An Investigation Using Data from the Taiwan Renal Registry Data System from 2005 to 2012.
    Lin YC; Lin YC; Hsu CY; Kao CC; Chang FC; Chen TW; Chen HH; Hsu CC; Wu MS;
    PLoS One; 2015; 10(6):e0129737. PubMed ID: 26107510
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conversion of oral alfacalcidol to oral calcitriol in the treatment of secondary hyperparathyroidism in chronic hemodialysis patients.
    Rauscher S; Lafrance JP; Pichette V; Bell RZ; Desforges K; Lepage L; Ouellet G; Ouimet D; Leblanc M; Lamarche C; Bezzaoucha S; Vallee M
    Int Urol Nephrol; 2017 Feb; 49(2):325-328. PubMed ID: 27822674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of Etelcalcetide vs Cinacalcet on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism: A Randomized Clinical Trial.
    Block GA; Bushinsky DA; Cheng S; Cunningham J; Dehmel B; Drueke TB; Ketteler M; Kewalramani R; Martin KJ; Moe SM; Patel UD; Silver J; Sun Y; Wang H; Chertow GM
    JAMA; 2017 Jan; 317(2):156-164. PubMed ID: 28097356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of long-term intravenous calcitriol administration on parathyroid function in hemodialysis patients.
    Rodriguez M; Felsenfeld AJ; Williams C; Pederson JA; Llach F
    J Am Soc Nephrol; 1991 Nov; 2(5):1014-20. PubMed ID: 1760537
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The calcimimetic AMG 073 reduces parathyroid hormone and calcium x phosphorus in secondary hyperparathyroidism.
    Lindberg JS; Moe SM; Goodman WG; Coburn JW; Sprague SM; Liu W; Blaisdell PW; Brenner RM; Turner SA; Martin KJ
    Kidney Int; 2003 Jan; 63(1):248-54. PubMed ID: 12472790
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term effects of intravenous 1 alpha (OH)D3 combined with CaCO3 and low-calcium dialysis on secondary hyperparathyroidism and biochemical bone markers in patients on chronic hemodialysis.
    Brandi L; Daugaard H; Nielsen PK; Jensen LT; Egsmose C; Olgaard K
    Nephron; 1996; 74(1):89-103. PubMed ID: 8883025
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Parathyroid function in patients on chronic intermittent hemodialysis (author's transl)].
    Augustin R; Hackeng WH
    Klin Wochenschr; 1977 Aug; 55(16):811-6. PubMed ID: 409876
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients.
    Slatopolsky E; Weerts C; Thielan J; Horst R; Harter H; Martin KJ
    J Clin Invest; 1984 Dec; 74(6):2136-43. PubMed ID: 6549016
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
    Nasri H; Baradaran A
    J Ayub Med Coll Abbottabad; 2004; 16(2):3-8. PubMed ID: 15455608
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vitamin D receptor genotype influences parathyroid hormone and calcitriol levels in predialysis patients.
    Marco MP; Martínez I; Amoedo ML; Borràs M; Saracho R; Almirall J; Fibla J; Fernández E
    Kidney Int; 1999 Oct; 56(4):1349-53. PubMed ID: 10504487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevated parathyroid hormone predicts mortality in dialysis patients undergoing valve surgery.
    Yan H; Sharma J; Weber CJ; Guyton RA; Perez S; Thourani VH
    Surgery; 2011 Dec; 150(6):1095-101. PubMed ID: 22136827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
    Nasri H; Baradaran A; Naderi AS
    Acta Med Austriaca; 2004 Aug; 31(3):67-72. PubMed ID: 15515479
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Values of intact serum parathyroid hormone in different stages of renal insufficiency.
    Hellman P; Backman U; Danielson BG; Akerström G; Rastad J; Wide L; Ljunghall S
    Scand J Urol Nephrol; 1991; 25(3):227-32. PubMed ID: 1947852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute effects of repetitive hemodialysis on circulating immunoreactive parathyroid hormone levels in uremic patients undergoing vitamin D (calcitriol) therapy.
    Bellazzi R; Romanini D; Bacchella L; Nai M; Aprile C; Santagostino M; De Vincenzi A
    Nephron; 1991; 57(3):273-82. PubMed ID: 2017266
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The relationship between total mass and blood supply of parathyroid glands and their secretion of parathyroid hormone in hemodialysis patients with secondary hyperparathyroidism.
    Ahmadi F; Aghajanzadeh P; Yazdi HR; Maziar S; Gatmiri SM
    Saudi J Kidney Dis Transpl; 2016 Mar; 27(2):263-9. PubMed ID: 26997379
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calcitriol and the parathyroid hormone-ionized calcium curve: a comparison of methodologic approaches.
    Ouseph R; Leiser JD; Moe SM
    J Am Soc Nephrol; 1996 Mar; 7(3):497-505. PubMed ID: 8704117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.